Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-03

Clinical Trial Update: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM [NA]

View source ↗

Summary

This completed clinical trial assessed the safety and efficacy of a fixed-ratio insulin degludec/insulin aspart regimen in adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • insulin degludec/insulin aspart (insulin degludec/insulin aspart)

Snippet

Sponsor: Beijing Hospital | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED